These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19769990)

  • 1. Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar.
    Mubayi A; Castillo-Chavez C; Chowell G; Kribs-Zaleta C; Ali Siddiqui N; Kumar N; Das P
    J Theor Biol; 2010 Jan; 262(1):177-85. PubMed ID: 19769990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kala-azar in Ballia district, Uttar Pradesh.
    Rao JS; Rahman SJ; Singh J; Singh SK
    J Commun Dis; 1992 Jun; 24(2):116-20. PubMed ID: 1344169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.
    Singh SP; Reddy DC; Rai M; Sundar S
    Trop Med Int Health; 2006 Jun; 11(6):899-905. PubMed ID: 16772012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of risk prone areas of kala-azar (Visceral leishmaniasis) in parts of Bihar State, India: an RS and GIS approach.
    Sudhakar S; Srinivas T; Palit A; Kar SK; Battacharya SK
    J Vector Borne Dis; 2006 Sep; 43(3):115-22. PubMed ID: 17024860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kala-azar elimination programme in India.
    Dhillon GP; Sharma SN; Nair B
    J Indian Med Assoc; 2008 Oct; 106(10):664, 666-8. PubMed ID: 19552101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis in Nepal during 1980-2006.
    Joshi DD; Sharma M; Bhandari S
    J Commun Dis; 2006 Mar; 38(2):139-48. PubMed ID: 17370676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sandfly survey in Nainital and Almora districts of Uttaranchal with particular reference to Phlebotomus argentipes, vector of kala-azar.
    Rao JS; Sharma SK; Bhattacharya D; Saxena NB
    J Commun Dis; 2001 Mar; 33(1):7-11. PubMed ID: 11898464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy for elimination of kala-azar from rural Bihar.
    Thakur CP
    Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
    Boelaert M; Meheus F; Sanchez A; Singh SP; Vanlerberghe V; Picado A; Meessen B; Sundar S
    Trop Med Int Health; 2009 Jun; 14(6):639-44. PubMed ID: 19392741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India.
    Kumar A; Saurabh S; Jamil S; Kumar V
    BMC Infect Dis; 2020 Jan; 20(1):10. PubMed ID: 31906924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and temporal variation and hotspot detection of kala-azar disease in Vaishali district (Bihar), India.
    Bhunia GS; Kesari S; Chatterjee N; Kumar V; Das P
    BMC Infect Dis; 2013 Feb; 13():64. PubMed ID: 23375077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India.
    Singh SP; Reddy DC; Mishra RN; Sundar S
    Am J Trop Med Hyg; 2006 Sep; 75(3):505-8. PubMed ID: 16968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An estimate of kala azar in 1991 in district Vaishali and Bihar.
    Bora D; Singh J; Bhattacharjee J; Kureel VR; Singh S; Sharma RS
    J Commun Dis; 1994 Jun; 26(2):120-2. PubMed ID: 7989675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.